Jefferies Group LLC Bolt Biotherapeutics, Inc. Transaction History
Jefferies Group LLC
- $10.2 Billion
- Q3 2022
Shares
3 transactions
Others Institutions Holding BOLT
# of Institutions
40Shares Held
24.3MCall Options Held
0Put Options Held
0-
Vivo Capital, LLC Palo Alto, CA3.52MShares$2.64 Million0.66% of portfolio
-
Tang Capital Management LLC San Diego, CA3.42MShares$2.57 Million0.58% of portfolio
-
Sofinnova Investments, Inc. Menlo Park, CA2.75MShares$2.07 Million0.22% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il2.42MShares$1.81 Million0.0% of portfolio
-
Pivotal Bio Venture Partners Investment Advisor LLC San Francisco, CA1.89MShares$1.42 Million1.94% of portfolio
About Bolt Biotherapeutics, Inc.
- Ticker BOLT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 37,641,500
- Market Cap $28.2M
- Description
- Bolt Biotherapeutics, Inc., a clinical-stage biotechnology company, engages in the development of immuno-oncology agents to target tumor cells for elimination by the immune system. The company is developing BDC-1001, a human epidermal growth factor receptor 2 (HER2), which is in Phase I/II clinical trial for the treatment of patients with HER2-e...